On Monday, in the course of current trade, Shares of Galena Biopharma Inc (NASDAQ:GALE), climbed 6.90%, and is now trading at $1.86.
Galena Biopharma, Inc. (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, recently declared that data from the Company’s Phase 2a portion of the Phase 1/2a clinical trial of GALE-301, or Folate Binding Protein, will be presented at the forthcoming European Society for Medical Oncology (ESMO) European Cancer Congress 2015 in Vienna, Austria. Details of the poster presentation are as follows:
Poster #:P427
Title: Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients
to prevent recurrence
Session Title: Gynaecological Cancer
Date: Monday, September 28, 2015
Time: 9:15 a.m. to 11:15 a.m. local time
Location:Hall C
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. Its commercial products comprise Abstral, a sublingual tablet that is used for the administration of breakthrough pain in patients with cancer; and Zuplenz, an oral soluble film for use in the prevention of chemotherapy-induced, radiotherapy-induced, and post-operative nausea and vomiting.
During an Afternoon trade, Shares of Hasbro, Inc. (NASDAQ:HAS), dipped -0.08%, and is now trading at $77.09.
Hasbro, declared that it will webcast its third quarter 2015 earnings conference call on Monday, October 19, 2015 at 8:30 a.m. Eastern Time, following the release of Hasbro’s financial results.
Hasbro, Inc., together with its auxiliaries, provides children’s and family leisure time products and services worldwide. The company’s product offerings comprise various toys comprising boys action figures, vehicles and playsets, girls toys, electronic toys and games, plush products, preschool toys and infant products, electronic interactive products, creative play, and toy-related specialty products.
Shares of SeaWorld Entertainment Inc (NYSE:SEAS), climbed 0.20%, and is now trading at $17.70.
SeaWorld Entertainment, declared a cash dividend of $0.21 per share of common stock. The dividend is payable on October 6, 2015 to shareholders of record at the close of business on September 29, 2015.
SeaWorld Entertainment, Inc. operates as a theme park and entertainment company in the United States. The company operates marine-life theme park under the SeaWorld brand name in Orlando, San Antonio, and San Diego; Busch Gardens theme parks, which are family-oriented destinations with foreign geographic settings in Tampa and Williamsburg; Discovery Cove marine-life theme park in Langhorne; and Sesame Place, a seasonal park in Langhorne. It also operates water parks under the Aquatica brand name in Orlando, San Antonio, and San Diego; under the Adventure Island name in Tampa; and under the Water Country USA name in Williamsburg.
Finally, NorthStar Asset Management Group Inc (NYSE:NSAM), gained 0.06% Monday.
NorthStar Asset Management Group has dropped 16.06% during the last 3-month period . Year-to-Date the stock performance stands at -23.87%. The company shares have dropped 9.22% in the past 52 Weeks. On March 5, 2015 The shares registered one year high of $24.91 and one year low was seen on August 26, 2015 at $16. The 50-day moving average is $17.56 and the 200 day moving average is recorded at $20.28. S&P 500 has rallied 1.82% during the last 52-weeks.
Northstar Asset Management Group Inc. provides asset administration and other services in the United States and internationally. It also offers securitization transaction services. The company is based in New York, New York. Northstar Asset Administration Group Inc. (NYSE:NSAM) operates independently of NorthStar Realty Finance Corp. as of June 30, 2014.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
